The observation that chronic GPER signaling may alter metabolic activity has potential significance regarding a role for GPER in cancer as prolonged, uninterrupted estrogen exposure (46) and metabolic syndrome (47) are independent risk factors for cancer. This evidence concerns the gene GPER1 and cancer.